147 related articles for article (PubMed ID: 37215985)
1. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer.
Chen YM; Xu W; Liu Y; Zhang JH; Yang YY; Wang ZW; Sun DJ; Li H; Liu B; Chen LX
Int J Biol Sci; 2023; 19(8):2531-2550. PubMed ID: 37215985
[TBL] [Abstract][Full Text] [Related]
2. Novel Withanolides from
Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
[TBL] [Abstract][Full Text] [Related]
3. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer.
Takatani-Nakase T; Ikushima C; Sakitani M; Nakase I
Life Sci; 2024 Feb; 339():122411. PubMed ID: 38184272
[TBL] [Abstract][Full Text] [Related]
4. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
Wang Y; Pang X; Liu Y; Mu G; Wang Q
Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
[TBL] [Abstract][Full Text] [Related]
5. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
[TBL] [Abstract][Full Text] [Related]
6. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin induced ferroptosis for triple-negative breast cancer therapy.
Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W
J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266
[TBL] [Abstract][Full Text] [Related]
9. WTAP Mediates NUPR1 Regulation of LCN2 Through m
Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
[TBL] [Abstract][Full Text] [Related]
10. Pitavastatin induces autophagy-dependent ferroptosis in MDA-MB-231 cells via the mevalonate pathway.
Tang WJ; Xu D; Liang MX; Wo GQ; Chen WQ; Tang JH; Zhang W
Heliyon; 2024 Mar; 10(5):e27084. PubMed ID: 38444467
[TBL] [Abstract][Full Text] [Related]
11. Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib.
Song X; Wang X; Liu Z; Yu Z
Front Oncol; 2020; 10():597434. PubMed ID: 33425751
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
Li J; He D; Li S; Xiao J; Zhu Z
Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
[TBL] [Abstract][Full Text] [Related]
13. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.
Wang Y; Sun Y; Wang F; Wang H; Hu J
Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026
[TBL] [Abstract][Full Text] [Related]
15. Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth.
Zhao H; Zhang M; Zhang J; Sun Z; Zhang W; Dong W; Cheng C; Yao Y; Li K
Cell Biosci; 2023 May; 13(1):87. PubMed ID: 37179385
[TBL] [Abstract][Full Text] [Related]
16. A Mitochondria-Targeted Ferroptosis Inducer Activated by Glutathione-Responsive Imaging and Depletion for Triple Negative Breast Cancer Theranostics.
Gan H; Huang X; Luo X; Li J; Mo B; Cheng L; Shu Q; Du Z; Tang H; Sun W; Wang L; Luo S; Yu S
Adv Healthc Mater; 2023 Sep; 12(22):e2300220. PubMed ID: 37204240
[TBL] [Abstract][Full Text] [Related]
17. Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer.
Zhang G; Mi W; Wang C; Li J; Zhang Y; Liu N; Jiang M; Jia G; Wang F; Yang G; Zhang L; Wang J; Fu Y; Zhang Y
Cell Death Discov; 2023 Dec; 9(1):457. PubMed ID: 38102129
[TBL] [Abstract][Full Text] [Related]
18. GPX4 degradation via chaperone-mediated autophagy contributes to antimony-triggered neuronal ferroptosis.
Yu S; Li Z; Zhang Q; Wang R; Zhao Z; Ding W; Wang F; Sun C; Tang J; Wang X; Zhang H; Huang R; Wu Q; Jiang J; Zhao X
Ecotoxicol Environ Saf; 2022 Apr; 234():113413. PubMed ID: 35305351
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.
Zhou TJ; Zhang MM; Liu DM; Huang LL; Yu HQ; Wang Y; Xing L; Jiang HL
Biomaterials; 2024 Mar; 305():122447. PubMed ID: 38154441
[TBL] [Abstract][Full Text] [Related]
20. High Intensity Focused Ultrasound-Driven Nanomotor for Effective Ferroptosis-Immunotherapy of TNBC.
Yu X; Li X; Chen Q; Wang S; Xu R; He Y; Qin X; Zhang J; Yang W; Shi L; Lu L; Zheng Y; Pang Z; Peng S
Adv Sci (Weinh); 2024 Apr; 11(15):e2305546. PubMed ID: 38342612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
